The ROle of Compression StocKings in Heart Failure Patients
压力袜对心力衰竭患者的作用
基本信息
- 批准号:10574068
- 负责人:
- 金额:$ 17.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAdverse eventAffectBilateralBody WeightBrain natriuretic peptideCardiomyopathiesCathetersCellulitisCessation of lifeChronicCitiesClassificationClinicalCompression StockingCreatinineDeteriorationDiseaseDiureticsDocumentationEdemaEnrollmentFemurFluid overloadGuidelinesHeartHeart AtriumHeart failureHospitalizationInterventionKansasKneeLegLower ExtremityMedicalNew YorkObstructionPainPatientsPeripheralPhysical PerformancePhysiciansPilot ProjectsPreventionPreventive measurePulmonary artery structureQuality of lifeQuestionnairesRandomizedRecommendationRefluxRenal functionRiskRoleSF-36SafetySaphenous VeinSerumShortness of BreathSigns and SymptomsStructure of popliteal veinSymptomsTelemedicineTestingTimeUnited StatesVaricose UlcerVenousVenous InsufficiencyVisitcompression therapycostdosagehuman old age (65+)improvedimproved mobilityinnovationmillisecondpressurepreventultrasoundwound
项目摘要
Project Summary:
Heart failure (HF) affects 6.2 million patients in the United States and was responsible of 13.4% of deaths in
2018 costing about 30.7 billion USD in 2012, and about 80% of all the patients with HF are >65 years old. Clinical
manifestations include shortness of breath and peripheral edema. Diuretics are indicated to treat edema in
patients with HF, however, its use is limited in patients with compromised kidney function. Peripheral edema is
associated with pain, heavy legs, limited mobility, and poor quality of life, increasing the risk of cellulitis, and
wounds. Heart failure was identified in up to 44% of patients with venous ulcers. The chronic use of compression
stockings in HF patients has potential benefits such as a better control of the edema, decreasing the need for
diuretics, improving mobility, prevention of progression of venous disease, and prevention of venous ulcers. To
date, no major HF guidelines recommend in favor or against compression stockings in HF patients.
The objective of this R21 proposal is to study the role of the compression stockings in preventing edema and
venous disease in heart failure patients.
Our hypothesis We hypothesize that the use of compression stockings will prevent developing or worsening
venous disease (venous reflux, and venous ulcers), improving the edema of the lower extremities, mobility, and
quality of life in HF patients without increasing the risk of HF deterioration, hospitalization, or death
In Aim 1 we are planning to randomize patients to high degree (20-30 mmHg) vs. low degree (10-15 mmHg)
compression stockings for 3 months and evaluate for clinical sign and symptoms of deterioration of heart failure,
as well as need to change in diuretic therapy at the end of the therapy.
In Aim 2a we are planning to evaluate if high degree compression stockings are associated with a difference in
time of valve closure (venous reflux) by venous duplex ultrasound at 3 months.
In Aim 2b we are planning to evaluate if high degree compression stockings are associated with a difference in
clinical signs of venous disease at 3 months.
In Aim 3 we are planning to evaluate if high degree compression stockings are associated with improvement in
mobility and quality of life at 3 months.
The contribution with this project is significant as edema and venous disease are very morbid condition in patients
with heart failure, and a simple and preventive measure such as compression stockings, could be safe and easily
implemented.
Our project is innovative as we are planning to use compression stockings in patients with heart failure,
something that physicians are reluctant to use due to possible decompensation and fluid overload. On the other
hand, we consider that it could be easily implemented and prevent advanced venous disease.
项目总结:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rafael S. Cires-Drouet其他文献
Rafael S. Cires-Drouet的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 17.3万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 17.3万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 17.3万 - 项目类别:














{{item.name}}会员




